Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Joseph Graziano Insider Profile
4 Followers
James Joseph Graziano, CTO at Eloxx Pharmaceuticals, holds 104.39K shares in Eloxx Pharmaceuticals (Ticker: ELOX).
James Joseph Graziano has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James Joseph Graziano's holdings
Insider Roles
CTO
Roles that James Joseph Graziano holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by James Joseph Graziano
James Joseph Graziano's Trading History
List of latest transactions for each holding click on a transaction to see James Joseph Graziano's performance on stock
You May Also Like
James Joseph Graziano insider profile FAQ
What is the percentage of profitable transactions made by James Joseph Graziano?
The percentage of profitable transactions made by James Joseph Graziano is ―.
What is the average return per transaction made by James Joseph Graziano?
The average return per transaction made by James Joseph Graziano is ―.
What stocks does James Joseph Graziano hold?
James Joseph Graziano holds: ELOX stocks.
What was James Joseph Graziano’s latest transaction?
James Joseph Graziano latest transaction was an Uninformative Buy of ―.
What was James Joseph Graziano's most profitable transaction?
James Joseph Graziano’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is James Joseph Graziano's role in Eloxx Pharmaceuticals?
James Joseph Graziano's role in Eloxx Pharmaceuticals is CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.